GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Plans » Clover Health Investments Corp (NAS:CLOV) » Definitions » Beta

Clover Health Investments (Clover Health Investments) Beta : 2.05 (As of May. 05, 2024)


View and export this data going back to 2021. Start your Free Trial

What is Clover Health Investments Beta?

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. As of today (2024-05-05), Clover Health Investments's Beta is 2.05.


Clover Health Investments Beta Historical Data

The historical data trend for Clover Health Investments's Beta can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clover Health Investments Beta Chart

Clover Health Investments Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Beta
- - - - 2.08

Clover Health Investments Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Beta Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 2.08

Competitive Comparison of Clover Health Investments's Beta

For the Healthcare Plans subindustry, Clover Health Investments's Beta, along with its competitors' market caps and Beta data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clover Health Investments's Beta Distribution in the Healthcare Plans Industry

For the Healthcare Plans industry and Healthcare sector, Clover Health Investments's Beta distribution charts can be found below:

* The bar in red indicates where Clover Health Investments's Beta falls into.



Clover Health Investments Beta Calculation

Beta is the sensitivity of the expected excess asset returns to the expected excess market returns. A stock's beta can be calculated by dividing the product of the covariance of the individual stock's returns and the market's returns by the variance of the market's returns over a specified period. Basically, GuruFocus uses the returns calculated over three-year period.


Clover Health Investments  (NAS:CLOV) Beta Explanation

Beta is a measure of the volatility, or systematic risk, of a security or a portfolio in comparison to the market as a whole. We usually compare beta to 1. A beta of 1 indicates that the security's price will move with the market. A beta of less than 1 means that the security will be less volatile than the market. A beta of greater than 1 indicates that the security's price will be more volatile than the market.

Beta is primarily used in the Capital Asset Pricing Model (CAPM) to calculate the Cost of Equity, which can be used in the calculation of WACC %. The formula of Cost of Equity is:
Cost of Equity = Risk-Free Rate of Return + Beta of Asset * (Expected Return of the Market - Risk-Free Rate of Return)


Clover Health Investments Beta Related Terms

Thank you for viewing the detailed overview of Clover Health Investments's Beta provided by GuruFocus.com. Please click on the following links to see related term pages.


Clover Health Investments (Clover Health Investments) Business Description

Traded in Other Exchanges
Address
3401 Mallory Lane, Suite 210, Franklin, TN, USA, 37067
Clover Health Investments Corp is a healthcare technology company. It uses its proprietary technology platform to collect, structure, & analyze health & behavioral data to improve medical outcomes & lower costs for patients. The Group has two operating segments. The insurance segment provides PPO(Preferred provider Organization) & HMO(Health Maintenance Organization) plans to Medicare Advantage members in several states & seeks to improve care & lower costs which generally provide access to a wide network of primary care providers, specialists, & hospitals. Non-insurance segment includes the Company's operations relating to CMS' DC (Direct Contracting) Model, which provides options aimed at reducing expenditures & preserving or enhancing the quality of care for beneficiaries.
Executives
Karen Soares officer: General Counsel & Secretary 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Clover Health Investments, Corp. /de officer: Chief Technology Officer 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Anna U Loengard director C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Andrew Toy director, officer: Chief Executive Officer C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN TN 37067
Scott J. Leffler officer: Chief Financial Officer C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Brady Patrick Priest officer: CEO of Home Care C/O CLOVER HEALTH INVESTMENTS, CORP., FRANKLIN TN 37067
Demetrios L. Kouzoukas director C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN FL 37067
Aric R Sharp officer: CEO of Value-Based Care C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Wai Conrad officer: Chief Technology Officer 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Joseph Richards Martin officer: General Counsel C/O LOUISIANA-PACIFIC CORPORATION, 414 UNION STREET, SUITE 2000, NASHVILLE TN 37219
Vivek Garipalli director, 10 percent owner, officer: Executive Chairperson C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN TN 37067
Carladenise Armbrister Edwards director C/O CLOVER HEALTH INVESTMENTS, CORP., 3401 MALLORY LANE, SUITE 210, FRANKLIN TN 37067
Chelsea Clinton director C/O IAC 555 W 18TH STREET, NEW YORK NY 10011
Jamie L. Reynoso officer: CEO of Medicare Advantage C/O CLOVER HEALTH INVESTMENTS, CORP., 725 COOL SPRINGS BLVD., SUITE 320, FRANKLIN TN 37067
Chamath Palihapitiya 10 percent owner, other: See Remarks THE SOCIAL-CAPITAL PARTNERSHIP, L.L.C., 506 SANTA CRUZ AVENUE, SUITE 300, MENLO PARK CA 94025

Clover Health Investments (Clover Health Investments) Headlines